David Barrett - Assembly Biosciences Insider

Assembly Biosciences Inc -- USA Stock  

USD 41.86  2.13  4.84%


Mr. David J. Barrett CPA, is Chief Financial Officer, Chief Operating Officer of Company. From April 2006 to September 2009, Mr. Barrett served as Chief Financial Officer of NeuroHitech, Inc., a public company focused on developing, marketing and distributing branded and generic pharmaceutical products. From September 2003 to April 2006, Mr. Barrett was the Chief Financial OfficerVice President of Finance of Overture Asset Managers and Overture Financial Services, which, at the time, was a startup asset management firm that assembled investment products and platforms to distribute turnkey and unbundled investment solutions to financial intermediaries and institutional investors. From July 1999 to September 2003, Mr. Barrett was employed as a Manager at Deloitte Touche, LLP. Mr. Barrett also is a director of Coronado Biosciences, Inc., a biopharmaceutical Company
Age: 38  COO Since 2015      
646 706-5208  www.ventrusbio.com
Barrett received his B.S. in Accounting and Economics and his M.S. in Accounting from the University of Florida. He is a certified public accountant.

David Barrett Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (29.25) % which means that it has lost $29.25 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (74.86) % meaning that it created substantial loss on money invested by shareholders.

Entity Summary

Assembly Biosciences, Inc., a biotechnology company, develops oral therapeutics for the treatment of hepatitis B virus infection and to restore health to a dysbiotic microbiome in the United States. Assembly Biosciences Inc (ASMB) is traded on Nasdaq Capital Markets in USA. It is located in NEW YORK, U.S.A and employs 65 people. Assembly Biosciences is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Pattern Recognition Now

Pattern Recognition

Use different Pattern Recognition models to time the market across multiple global exchanges
Hide  View All  NextLaunch Pattern Recognition
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Assembly Biosciences Inc to your portfolio

Top Management

Assembly Biosciences Inc Leadership Team
Adam Zlotnick, Founder
Uri Lopatin, President, Ph.D
Myron Holubiak, Director
Lee Arnold, Executive, Ph.D
Anthony Altig, Director
Richard Colonno, Executive
William Ringo, Chairman, MBA
Richard DiMarchi, Director, Ph.D
Miguel Barbosa, Executive, Ph.D
Thomas Rollins, Executive
Mark Auerbach, Director
Derek Small, CEO
Alan Lewis, Director, Ph.D
David Barrett, COO

Stock Performance

Assembly Biosciences Performance Indicators